Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITDAOperating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HUTCHMED (China) (HCM) EBIT: 2018-2021

Historic EBIT for HUTCHMED (China) (HCM) over the last 3 years, with Dec 2021 value amounting to -$252.5 million.

  • HUTCHMED (China)'s EBIT was N/A to -$252.5 million in Q4 2021 from the same period last year, while for Dec 2021 it was $341.0 million, marking a year-over-year change of. This contributed to the annual value of -$43.7 million for FY2024, which is 337.85% down from last year.
  • HUTCHMED (China)'s EBIT amounted to -$252.5 million in Q4 2021, which was down 214.82% from $219.9 million recorded in Q2 2021.
  • HUTCHMED (China)'s EBIT's 5-year high stood at $308.7 million during Q2 2019, with a 5-year trough of -$559.5 million in Q4 2019.
  • For the 3-year period, HUTCHMED (China)'s EBIT averaged around $34.9 million, with its median value being $133.0 million (2020).
  • Over the last 5 years, HUTCHMED (China)'s EBIT had its largest YoY gain of 784.83% in 2019, and its largest YoY loss of 1,880.58% in 2019.
  • Quarterly analysis of 4 years shows HUTCHMED (China)'s EBIT stood at -$28.2 million in 2018, then plummeted by 1,880.58% to -$559.5 million in 2019, then plummeted by 50.45% to $153.0 million in 2020, then soared by 43.72% to -$252.5 million in 2021.
  • Its last three reported values are -$252.5 million in Q4 2021, $219.9 million for Q2 2021, and $220.6 million during Q1 2021.